Blueprint Medicines Corp (BPMC)
84.84
-0.36
(-0.43%)
USD |
NASDAQ |
Apr 16, 10:17
Blueprint Medicines Total Return Price: 84.84 for April 16, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 15, 2024 | 85.20 |
| April 12, 2024 | 87.25 |
| April 11, 2024 | 92.25 |
| April 10, 2024 | 90.49 |
| April 09, 2024 | 92.20 |
| April 08, 2024 | 91.54 |
| April 05, 2024 | 91.65 |
| April 04, 2024 | 90.68 |
| April 03, 2024 | 92.23 |
| April 02, 2024 | 91.56 |
| April 01, 2024 | 96.42 |
| March 28, 2024 | 94.86 |
| March 27, 2024 | 94.79 |
| March 26, 2024 | 89.67 |
| March 25, 2024 | 88.22 |
| March 22, 2024 | 87.04 |
| March 21, 2024 | 90.05 |
| March 20, 2024 | 88.26 |
| March 19, 2024 | 87.97 |
| March 18, 2024 | 86.82 |
| March 15, 2024 | 90.50 |
| March 14, 2024 | 87.71 |
| March 13, 2024 | 90.60 |
| March 12, 2024 | 89.70 |
| March 11, 2024 | 89.47 |
| Date | Value |
|---|---|
| March 08, 2024 | 92.30 |
| March 07, 2024 | 92.04 |
| March 06, 2024 | 90.38 |
| March 05, 2024 | 89.67 |
| March 04, 2024 | 90.80 |
| March 01, 2024 | 95.12 |
| February 29, 2024 | 93.52 |
| February 28, 2024 | 95.45 |
| February 27, 2024 | 99.79 |
| February 26, 2024 | 95.05 |
| February 23, 2024 | 89.49 |
| February 22, 2024 | 86.00 |
| February 21, 2024 | 87.26 |
| February 20, 2024 | 91.25 |
| February 16, 2024 | 90.26 |
| February 15, 2024 | 87.57 |
| February 14, 2024 | 76.80 |
| February 13, 2024 | 73.17 |
| February 12, 2024 | 77.54 |
| February 09, 2024 | 76.54 |
| February 08, 2024 | 74.16 |
| February 07, 2024 | 74.20 |
| February 06, 2024 | 77.17 |
| February 05, 2024 | 76.66 |
| February 02, 2024 | 79.58 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
37.97
Minimum
Feb 24 2023
124.48
Maximum
Dec 23 2020
74.83
Average
74.67
Median
Jul 24 2020
Total Return Price Benchmarks
| Alnylam Pharmaceuticals Inc | 148.17 |
| Apellis Pharmaceuticals Inc | 52.87 |
| Ionis Pharmaceuticals Inc | 41.92 |
| Madrigal Pharmaceuticals Inc | 226.80 |
| Sarepta Therapeutics Inc | 118.40 |